M. D. Tanriover Et Al. , "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey," LANCET , vol.398, no.10296, pp.213-222, 2021
Tanriover, M. D. Et Al. 2021. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. LANCET , vol.398, no.10296 , 213-222.
Tanriover, M. D., Doganay, H. L., AKOVA, M., GÜNER, H. R., Azap, A., AKHAN, S., ... Kose, S.(2021). Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. LANCET , vol.398, no.10296, 213-222.
Tanriover, Mine Et Al. "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey," LANCET , vol.398, no.10296, 213-222, 2021
Tanriover, Mine D. Et Al. "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey." LANCET , vol.398, no.10296, pp.213-222, 2021
Tanriover, M. D. Et Al. (2021) . "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey." LANCET , vol.398, no.10296, pp.213-222.
@article{article, author={Mine Durusu Tanriover Et Al. }, title={Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey}, journal={LANCET}, year=2021, pages={213-222} }